Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. Income Statement 2017–2020
| Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 7.9M | 22.5M | 9.7M | 8.4M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | -82.2M | -32.2M | -36.0M | -26.2M |
| EBITDA | -81.5M | -30.9M | -34.7M | -25.0M |
| Net Income | -74.8M | -31.8M | -34.5M | -25.5M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 32M | 8M | 30M | 10M |
Cogent Biosciences, Inc. Income Statement — FAQ
Cogent Biosciences, Inc. (COGT) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's income statement history?
The chart and table above show Cogent Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.